Silver Book Fact

Between 1984 and 1998, the cost of treating heart attack patients rose $10,000. However, medical technology increased the life expectancy of heart attack patients by an average of 1 year-a value of $70,000 and a net benefit of $60,000.

Cutler, David M. and Mark McClellan. Is Technological Change in Medicine Worth It?. Health Affairs. 2001; 20(5): 11-29. http://content.healthaffairs.org/content/20/5/11.full

Reference

Title
Is Technological Change in Medicine Worth It?
Publication
Health Affairs
Publication Date
2001
Authors
Cutler, David M. and Mark McClellan
Volume & Issue
Volume 20, Issue 5
Pages
11-29
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • An estimated 70% of survival improvement in heart attack mortality is attributed to technological advances and procedures developed over the past 30 years, including CABG (coronary artery bypass graft), PTCA…  
  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.  
  • Beta-Blocker Treatment After A Heart Attack: Trends, 1996-2006